Company / Tangible Book Value per Share
NovaBay Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$0.03
FY2024
5-year range
-$0.03 / $5.02
FY2020-FY2024
Trend
-108.9%
vs FY2023
Sector context
#185 of 211
Health Care
What the data says
NovaBay Pharmaceuticals, Inc.'s tangible book value per share of $-0.03 is lower than 88% of companies in the Health Care sector (FY2024). Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-2.47 in FY2015 to $5.02 in FY2022.
Based on SEC 10-K filings.
-0.03 in FY2024.
Declined from $5.02 to $-0.03 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-100.0% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share decreased 108.9% year-over-year.
- Ranks #185 out of 211 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
- Lowest tangible book value per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.03 | -108.9% |
| FY2023 | $0.30 | -94.1% |
| FY2022 | $5.02 | +3780.0% |
| FY2021 | $0.13 | -63.2% |
| FY2020 | $0.35 | +681.1% |
| FY2019 | $0.04 | -84.5% |
| FY2018 | $0.29 | +70.9% |
| FY2017 | $0.17 | -91.7% |
| FY2016 | $2.04 | +182.6% |
| FY2015 | -$2.47 | -6058.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026